- Study at Deakin
- Campus life
- Industry and community
- About Deakin
Professor Wei Duan is the Director of Nanomedicine Program in the School of Medicine. Professor Duan currently holds a number of national competitive grants from National Health & Medical Research Council and Australian Government Department of Innovation, Industry, Science and Research. He has attracted a total of $1.5 million external grant funds since his initial appointment to Deakin University in 2006.
HME101 Human Biology, Coordinator and Principal Lecturer
H413 School of Medicine Honours Program, Lecturer.
Professor Duan's research focuses on developing RNA aptamer technology for cancer biotechnology, targeted cancer drug delivery using nanoparticles as well as aptamber-based molecular imaging for early detection of cancer and accurate staging. He heads a cross-disciplinary and translational research team consisting of cancer biologists, oncologists, molecular and cell biologists, material scientists, organic chemists, drug developers, pharmaceutical scientists and mechanical and electronic engineers across several faculties, research centres and teaching hospitals in Deakin. He is also involved in developing novel aptamer-based and microfluidic lab-on-a-chip devices for the application in biodefense, forensic medicine and rapid diagnostics at the point of care. He has published over 104 peer-reviewed original research papers and review articles in international refereed journals.
1) Researcher of the Year Awards 2008 - Biotechnology Award from Department of Innovation, Industry and Regional Development, State Government of Victoria and Smart Geelong Network.
2) Researcher of the Year –2011, Smart Geelong Network
Deputy Chair, Deakin University Laboratory Safety Committee
FHMNBS Human Research Ethics Committee
FHMNBS Academic Promotion Committee (2008)
Chair, Higher Degree by Research Committee, School of Medicine (2008-09)
Coordinator, HME101 - Human Biology, School of Medicine
Year 1 & 2 Teaching and Learning Committee, School of Medicine
Executive Committee for Strategic Research Centre-MolecularMedical Research
Assessment Committee, School of Medicine
Ph.D. Confirmation Committee, School of Medicine
Academic Staff Appointment Committee, School of Health and Social Development (2008-09)
Academic Staff Appointment Committee, School of Nursing (2009)
1. Wei Duan, ‘A Novel Paradigm in Mammalian Cell Signaling’, Signal Transduction—Targets for effective therapeutics, Cambridge Healthtech Institute, Seaport Hotel, Boston, MA, USA, November 8-9, 2004. [My talk was reviewed in ‘Rounding up the usual suspects: protein kinases as the therapeutic targets’, S.B. Shears, Drug Discovery Today.10(4):240-242, 2005.]
2. Wei Duan, ‘Signaling via a novel integral plasma membrane pool of protein kinase C’, The Hunter Meeting of Cell Biology, Sydney, Australia, 6-8 April, 2005.
3. Wei Duan, ‘Herbal Medicine In Australia—Transforming Ancient Remedy With Nanotechnology’, 59th Indian Pharmaceutical Congress, Varanasi-221 005, Uttar Pradesh, India, 20-23 December, 2007.
4. Wei Duan, ‘Development of Molecular Medicine that Specifically Targets Protein Kinase C in Heart Failure’, 10th South China International Congress of Cardiology, Dongfang Hotel, Guangzhou, China, 10-13, April, 2008.
5. Wei Duan, ‘Targeted drug delivery using RNA aptamer and nanoparticles—the miracle of nanomedicine for the 21st century’. VII Thailand Research Fund (TRF) Annual Congress. October 16-18, 2008, Holiday Inn Resort Regent Beach, Cha-Am, Thailand.
6. Wei Duan, ‘Aptamer therapeutics: the 21st century’s magic bullet of nanomedicine’, Second International Conference on Drug Discovery and Therapy'. February 1-4, 2010. Dubai, United Arab Emirates.
7. Wei Duan, ‘Nucleic acid aptamer: the pearl in the crown of nanomedicine for molecular imaging of cancer’, The 4th International Symposium on Bioanalysis, Biomedical Engineering and Nanotechnology (ISBBN 2010), Hunan University in Changsha, Hunan, China (June 3-6, 2010).
8. Wei Duan, RNA Aptamer: The Next Generation of Cancer Stem Cell-targeted Molecular Imaging, BIT’s 9th Annual Congress of International Drug Discovery Science and Technology --- Re-think Drug Innovations in Green-Eco Era (Session 7-1-2: Nucleic Acid Therapeutics), November 3-6, 2011, Shenzhen, China.